LUMAKRAS® (SOTORASIB) RECEIVES APPROVAL IN JAPAN FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCERPRNewsWire • 01/20/22
TEZSPIRE™ (TEZEPELUMAB-EKKO) NOW AVAILABLE IN THE UNITED STATES FOR THE TREATMENT OF SEVERE ASTHMAPRNewsWire • 01/13/22
Amgen, Inc. (AMGN) CEO Robert Bradway Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/11/22
AMGEN AND ARRAKIS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO IDENTIFY NOVEL RNA DEGRADER SMALL MOLECULE THERAPEUTICSPRNewsWire • 01/11/22
AMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE THAT KARMA BIOTECHNOLOGIES WILL RECEIVE THE SECOND AMGEN GOLDEN TICKETPRNewsWire • 01/10/22
EUROPEAN COMMISSION APPROVES LUMYKRAS® (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCERPRNewsWire • 01/10/22
Amgen, Inc. (AMGN) Presents at Goldman Sachs 14th Annual Healthcare CEOs Unscripted Broker Conference Call - (Transcript)Seeking Alpha • 01/06/22
Amgen could pay Generate Biomedicines up to $1.9 billion as part of research collaboration agreementMarket Watch • 01/06/22
AMGEN AND GENERATE BIOMEDICINES ANNOUNCE MULTI-TARGET, MULTI-MODALITY RESEARCH COLLABORATION AGREEMENTPRNewsWire • 01/06/22